The studyconductedby theInternationalSchizophreniaConsortiumalsocomparedtheSNPpatternsinschizophreniapatientsandthe genomes of people with otherdiseases.
Of course, Orchid isn't the only company hunting SNPs, and even its new deal with the SNPconsortium doesn't mean that Orchid's way of finding them will become the standard.